In this episode of the Oncology Brothers podcast, we dived deep into the complexities of pancreatic cancer treatment with Dr. Shubham Pant, a GI medical oncologist at MD Anderson Cancer Center.
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o
Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
• The challenges of diagnosing and treating pancreatic cancer, particularly in metastatic settings.
• The importance of germline testing and next-generation sequencing (NGS) in guiding treatment decisions.
• The role of neoadjuvant and adjuvant therapies, including FOLFIRINOX and Gemcitabine-based regimens.
• Strategies for managing borderline resectable disease and the significance of multidisciplinary care.
• The critical aspect of supportive care, including the use of pancreatic enzyme replacement therapy.
• Insights into treatment options for metastatic disease, including FOLFIRINOX, NALIRIFOX, and Gemcitabine-Nab-paclitaxel.
• The emerging landscape of targeted therapies for KRAS mutations and the potential of pan-RAS inhibitors.
Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode provides valuable insights into the evolving treatment algorithms for pancreatic cancer.
Don't forget to like, subscribe, and hit the notification bell for more discussions on cancer treatment and care!
#PancreaticCancer, #KRASmutation, #NeoadjuvantTherapy, #SupportiveCare, #OncBrothers